These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 4276446
1. Effect of age, obesity, starvation, and changes in adrenocortical and ovarian activity on the urinary excretion of dehydroepiandrosterone relative to androsterone plus etiocholanolone: relevance to the measurement of breast cancer discriminants in women. Metcalf MG. Clin Biochem; 1974 Jun; 7(2):119-30. PubMed ID: 4276446 [No Abstract] [Full Text] [Related]
2. The breast cancer discriminant: effect of age, obesity, hirsutism, starvation, and changes in adrenocortical and gonadal activity. Metcalf MG. J Endocrinol; 1974 Nov; 63(2):263-74. PubMed ID: 4374483 [No Abstract] [Full Text] [Related]
3. The urinary dehydroepiandrosterone, androsterone and etiocholanolone excretion of healthy women and women with benign and malignant breast disease. Ivanović S, Agbaba D, Zivanov-Stakić D, Konstantinović I. J Clin Pharm Ther; 1990 Jun; 15(3):213-9. PubMed ID: 2142165 [Abstract] [Full Text] [Related]
4. A comparison of urinary 17-hydroxycorticosteroid and 11-deoxy-17-oxosteroid excretion in obesity, in thyroid dysfunction and in early breast cancer. Sneddon A, Steel JM, Strong JA. J Endocrinol; 1969 Feb; 43(2):48-9. PubMed ID: 4237784 [No Abstract] [Full Text] [Related]
6. Urinary excretion of 11-deoxy-17-ketosteroids by patients with breast cancer with or without ovulatory cycles. Grattarola R. J Endocrinol; 1967 May; 38(1):77-8. PubMed ID: 4225834 [No Abstract] [Full Text] [Related]
8. Discriminant function based on steroid abnormalities in patients with lung cancer. Rao LG. Lancet; 1970 Aug 29; 2(7670):441-5. PubMed ID: 4195119 [No Abstract] [Full Text] [Related]
9. A comparative study of the urinary excretion of glucocorticoids and 11-deoxy-17-ketosteroids in a group of obese women. Hendrikx A, Meulepas E, Heyns W, De Moor P. Ann Endocrinol (Paris); 1974 Aug 29; 35(4):508-20. PubMed ID: 4283406 [No Abstract] [Full Text] [Related]
11. Excretion of urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids by women using steroidal contraceptives. Bulbrook RD, Hayward JL. Lancet; 1969 Nov 15; 2(7629):1033-5. PubMed ID: 4187543 [No Abstract] [Full Text] [Related]
12. Analysis of a dexamethasone-chorionic gonadotrophin test of adreno-gonadal function in normal men as compared with dexamethasone test in normal women. Johnsen SG, Christiansen P, Frandsen VA, Froland A, Nielsen J. Acta Endocrinol (Copenh); 1971 Apr 15; 66(4):587-605. PubMed ID: 4251843 [No Abstract] [Full Text] [Related]
13. Effect of thyroid funtion and of obesity on discriminant function for mammary carcinoma. Sneddon A, Steel JM, Strong JA. Lancet; 1968 Oct 26; 2(7574):892-4. PubMed ID: 4176150 [No Abstract] [Full Text] [Related]
14. [Urinary excretion of 11-deoxy-17-ketosteroids during the normal menstrual cycle (author's transl)]. Bolufer P, Rodríguez A, Micó JM. Rev Esp Fisiol; 1975 Jun 26; 31(2):115-8. PubMed ID: 125907 [Abstract] [Full Text] [Related]
17. Urinary 17-ketosteroid fractions in young patients with breast cancer. Chiricuţă I, Frenkel Z, Muteanu S. Endocrinologie; 1978 Jun 26; 16(2):135-7. PubMed ID: 150018 [Abstract] [Full Text] [Related]
18. [Fluctuation of the urinary 17KS levels during the administration of dexamethasone and HCG in women with normal menstrual cycles]. Yoshida T, Kamata S, Ito H, Sagara Y, Konishi H. Horumon To Rinsho; 1972 Oct 26; 20(10):857-61. PubMed ID: 4265688 [No Abstract] [Full Text] [Related]